- Insider Monkey
Here’s Why Evolent Health (EVH) Declined in Q4
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. Small-cap stocks posted solid returns in the fourth quarter for the first time in 2022. The Russell 2000 Growth Index was up 4.11% trailing the Russell 2000 […]
- Benzinga
This Analyst Is Bullish On Evolent Health's Recent Deal, Calls 'Highly Strategic Acquisition'
Thursday after close, Evolent Health Inc (NYSE: EVH) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance. William Blair is positive on the acquisition and believes this is consistent with management's prior commentary that Evolent would consider strategic assets that fit under the specialty care man
- Benzinga
Centene Agrees To Divest Magellan Specialty Health To Evolent Health
Evolent Health Inc (NYSE: EVH) has agreed to acquire NIA (also known as Magellan Specialty Health), the specialty benefit management organization owned by Centene Corporation (NYSE: CNC). The organization focuses on managing cost and quality in radiology, musculoskeletal, physical medicine, and genetics. Deal consideration includes $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance. The upfront consideration will be partly funded by
